pSivida Limited | ||
|
|
|
Date: January 5, 2006 | By: | /s/ Aaron Finlay |
|
||
Aaron
Finlay
Chief
Financial Officer and Company
Secretary
|
EXHIBIT
99.1:
|
Appendix
3X Initial Director’s Interest
Notice
|
Name
of entity
|
PSIVIDA
LIMITED
|
ABN
|
78
009 232 026
|
Name
of Director
|
Dr
Paul Ashton
|
Date
of appointment
|
30
December 2005
|
Number
& class of securities
17,664,080
fully paid ordinary shares (represented by 1,766,408 American Depositary
Shares)
352,280
unquoted options to acquire ordinary shares (represented by options
to
acquire 35,228 ADSs) expiring 25 August 2009, exercisable at US$0.22709
per share (or US$2.2709 per ADS)
528,420
unquoted options to acquire ordinary shares (represented by options
to
acquire 52,842 ADSs) expiring 18 September 2007, exercisable at
US$0.17742
per share (or US$1.7742 per ADS)
500,000
unquoted options to acquire ordinary shares expiring 30 September
2010,
exercisable at A$0.92 per share
|
Name
of holder & nature of interest
Note:
Provide details of the circumstances giving rise to the relevant
interest
|
Number
& class of Securities
|
N/A
|
N/A
|
Detail
of contract
|
|
Nature
of interest
|
|
Name
of registered holder
(if
issued securities)
|
|
No.
and class of securities to which interest relates
|